Prostaglandin receptor EP₁-mediated differential degradation of cyclooxygenases involves a specific lysine residue

Abstract

The cyclooxygenase (COX) enzyme isoforms COX-1 and COX-2 catalyze the main step in the generation of prostanoids that mediate major physiological functions. Whereas COX-1 is a ubiquitously expressed stable protein, COX-2 is transiently upregulated in many pathologies and is often associated with a poor prognostic outcome. We have recently shown that an interaction of COX-2 with the prostaglandin EP₁ receptor accelerates its degradation via a mechanism that augments its level of ubiquitination. Here we show that the sensitivity of both COX-1 and COX-2 to EP₁ is altered upon modification of one lysine residue. A point mutation of lysine to-arginine in position 432 of COX-2 (K432R) yields an enzyme with decreased sensitivity to EP₁ -mediated degradation. In contrast, insertion of a putative ubiquitination site into the corresponding position of COX-1 (H446K') yields an enzyme with higher levels of ubiquitination and reduced expression. Furthermore, compared to wild type COX-1, H446K' is significantly more sensitive to downregulation by EP₁ . Together these data suggest that distinctive ubiquitination of COX-1 and COX-2 may be responsible for their different sensitivity to EP₁ -mediated degradation.

Keywords: COX-1; COX-2; Cyclooxygenase; Degradation; EP(1); Ubiquitination.